China’s healthcare system was unprepared for the Chinese Communist Party’s drastic change in its COVID-19 policy, resulting in widespread drug shortages and soaring prices.
According to a Dec. 19 report by China’s NetEase News, in Beijing and Tianjin, the fever-reducer ibuprofen for adults and children has become hard to find.
At present, Meilin (ibuprofen suspension) is not available in offline stores in Beijing. Citizens in need contact multiple parties and seek to buy it everywhere.
At the gate of Tianjin Children’s Hospital, a bottle of Meilin, originally priced at about 20 yuan ($2.8), is even being sold for 2,500 to 3,000 yuan ($350-420)….